VTX

Vortioxetine

Created:2022-09-02
Last modified:  2024-03-06

Help

Find related ligands:

Chemical Details

Formal Charge0
Atom Count43
Chiral Atom Count0
Bond Count45
Aromatic Bond Count12
2D diagram of VTX

WebGL does not seem to be available.

This can be caused by an outdated browser, graphics card driver issue, or bad weather. Sometimes, just restarting the browser helps. Also, make sure hardware acceleration is enabled in your browser.

For a list of supported browsers, refer to http://caniuse.com/#feat=webgl.

Toggle HydrogenToggle Labels

Chemical Component Summary

NameVortioxetine
Synonyms1-[2-(2,4-dimethylphenyl)sulfanylphenyl]piperazine; 1-(2-((2,4-Dimethylphenyl)thio)phenyl)piperazine
Systematic Name (OpenEye OEToolkits)1-[2-(2,4-dimethylphenyl)sulfanylphenyl]piperazine
FormulaC18 H22 N2 S
Molecular Weight298.446
TypeNON-POLYMER

Chemical Descriptors

TypeProgramVersionDescriptor
SMILESCACTVS3.385Cc1ccc(Sc2ccccc2N3CCNCC3)c(C)c1
SMILESOpenEye OEToolkits3.1.0.0Cc1ccc(c(c1)C)Sc2ccccc2N3CCNCC3
Canonical SMILESCACTVS3.385 Cc1ccc(Sc2ccccc2N3CCNCC3)c(C)c1
Canonical SMILESOpenEye OEToolkits3.1.0.0 Cc1ccc(c(c1)C)Sc2ccccc2N3CCNCC3
InChIInChI1.06 InChI=1S/C18H22N2S/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-11-9-19-10-12-20/h3-8,13,19H,9-12H2,1-2H3
InChIKeyInChI1.06 YQNWZWMKLDQSAC-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank IDDB09068 
NameVortioxetine
Groups
  • approved
  • investigational
DescriptionVortioxetine is an antidepressant medication indicated for the treatment of major depressive disorder (MDD). It is classified as a serotonin modulator and stimulator (SMS) as it has a multimodal mechanism of action towards the serotonin neurotransmitter system whereby it simultaneously modulates one or more serotonin receptors and inhibits the reuptake of serotonin. More specifically, vortioxetine acts via the following biological mechanisms: as a serotonin reuptake inhibitor (SRI) through inhibition of the serotonin transporter, as a partial agonist of the 5-HT1B receptor, an agonist of 5-HT1A, and an antagonist of the 5-HT3, 5-HT1D, and 5-HT7 receptors. SMSs were developed because there are many different subtypes of serotonin receptors, however, not all of these receptors appear to be involved in the antidepressant effects of SRIs. Some serotonin receptors seem to play a relatively neutral or insignificant role in the regulation of mood, but others, such as 5-HT1A autoreceptors and 5-HT7 receptors, appear to play an oppositional role in the efficacy of SRIs in treating depression.
Synonyms
  • Vortioxetine hydrobromide
  • Vortioxétine
  • vortioxetinum
  • Vortioxetine
  • Vortioxetina
Brand Names
  • Trintellix
  • Brintellix
IndicationVortioxetine is indicated for the treatment of major depressive disorder (MDD).
Categories
  • Agents that produce hypertension
  • Anti-Anxiety Agents
  • Antidepressive Agents
  • Antidepressive Agents Indicated for Depression
  • Central Nervous System Agents
ATC-CodeN06AX26
CAS number508233-74-7

Drug Targets

NameTarget SequencePharmacological ActionActions
Sodium-dependent serotonin transporterMETTPLNSQKQLSACEDGEDCQENGVLQKVVPTPGDKVESGQISNGYSAV...unknowninhibitor
5-hydroxytryptamine receptor 3AMLLWVQQALLALLLPTLLAQGEARRSRNTTRPALLRLSDYLLTNYRKGVR...unknownantagonist
5-hydroxytryptamine receptor 7MMDVNSSGRPDLYGHLRSFLLPEVGRGLPDLSPDGGADPVAGSWAPHLLS...unknownantagonist
5-hydroxytryptamine receptor 1BMEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKV...unknownpartial agonist
5-hydroxytryptamine receptor 1AMDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCA...unknownagonist
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL2104993
PubChem 9966051
ChEMBL CHEMBL2104993
ChEBI CHEBI:76016
CCDC/CSD HUDXIP, HUDXEL, EWAZEJ, EWAYUY
COD 2311291, 2311290